EUVIMEDEUVIMED entdecken
Crossref

Reprogramming anti-tumor immunity through both NLRP3 inflammasome and cGAS-STING pathways by chiral nanoadjuvants

Panpan Chen, Weiwei Wang, Aihua Qu, Yihui Hua, Jéssica Cristiane Magalhães Ierich, André Farias de Moura, Liguang Xu, Hua Kuang, Chuanlai Xu, Maozhong Sun

Science Bulletin · 2026-06 · 71 (11) · 2740-2757

DOI: 10.1016/j.scib.2026.03.050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Bulletin, 2026-06. Verfasst von Panpan Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi 214122, China. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Cancer Vaccines, cGAS-STING Signaling Pathway, Inflammasomes. Die Arbeit nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has shown significant promise but faces challenges due to concerns around safety, the complex tumor microenvironment, and the low immunogenicity of cancer vaccines. Here, we report the synthesis of degradable chiral trimanganese tetroxide nanoparticles (Mn3O4 NPs) by modifying chiral mannose ligands to create chiral vaccines for cancer therapy and prevention. The L-type Mn3O4 nanoparticles (L-NPs) exhibit nearly twice the uptake rate into mouse bone marrow dendritic cells (BMDCs) compared to D-type Mn3O4 nanoparticles (D-NPs), thanks to a higher affinity for X-C motif chemokine ligand 1 (XCR1), cluster of differentiation 14 (CD14), and Toll-like receptor 4 (TLR4). When loaded with tumor antigens as vaccines (L-Vac), the L-NPs activate BMDCs through both NOD-like receptor protein 3 (NLRP3) inflammasome and cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathways, enhancing the levels of C-C motif chemokine ligand 5 (CCL5) and reducing C-C motif chemokine ligand 22 (CCL22) expression. Molecular dynamics (MD) simulation explored the lock-and-key mechanism on the chiral NPs distinct patterns of interaction with antigen. Noticeably, the anti-tumor immunity was successfully confirmed in patient-derived xenograft (PDX) mouse model, depicting the clinical potential of chiral vaccines. L-Vac demonstrates high in vivo biosafety, breaking down into manganese ions that are primarily excreted through feces. Therefore, chiral adjuvants will pave a brilliant avenue to facilitate cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adjuvants, ImmunologicCancer VaccinescGAS-STING Signaling PathwayInflammasomesMembrane ProteinsNanoparticlesNeoplasmsNLR Family, Pyrin Domain-Containing 3 ProteinNucleotidyltransferasesAnimalsHumansMiceChemokine CCL5Cyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDendritic CellsMice, Inbred C57BLSTING Protein

Stichwörter der Autor:innen

AdjuvantsBiodegradableCCL22CCL5CancerChiralImmunityMn(3)O(4) NPsNLRP3cGAS-STING

Substanzen

Adjuvants, ImmunologicCancer VaccinesCcl5 protein, mousecGAS protein, mouseChemokine CCL5Cyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseInflammasomesMembrane ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouse

Autor:innen und Institutionen

  • International Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi 214122, China.
  • International Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi 214122, China; Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical Un…
  • Jiangnan University Medical Center, Wuxi 214122, China.
  • Department of Chemistry, Federal University of São Carlos, São Carlos 13565-905, Brazil.
  • Department of Chemistry, Federal University of São Carlos, São Carlos 13565-905, Brazil. Electronic address: moura@ufscar.br.
  • International Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi 214122, China. Electronic address: kuangh@jiangnan.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • National Council for Scientific and Technological Development
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Chen, P., Wang, W., Qu, A., Hua, Y., Ierich, J. C. M., de Moura, A. F., Xu, L., Kuang, H., Xu, C., & Sun, M. (2026). Reprogramming anti-tumor immunity through both NLRP3 inflammasome and cGAS-STING pathways by chiral nanoadjuvants. Science Bulletin, 71(11), 2740-2757. https://doi.org/10.1016/j.scib.2026.03.050

Vancouver

Chen P, Wang W, Qu A, Hua Y, Ierich JCM, de Moura AF, et al. Reprogramming anti-tumor immunity through both NLRP3 inflammasome and cGAS-STING pathways by chiral nanoadjuvants. Science Bulletin. 2026;71(11):2740-2757. doi:10.1016/j.scib.2026.03.050

BibTeX
@article{Chen2026,
  author = {Chen, Panpan and Wang, Weiwei and Qu, Aihua and Hua, Yihui and Ierich, Jéssica Cristiane Magalhães and de Moura, André Farias and Xu, Liguang and Kuang, Hua and Xu, Chuanlai and Sun, Maozhong},
  title = {Reprogramming anti-tumor immunity through both NLRP3 inflammasome and cGAS-STING pathways by chiral nanoadjuvants},
  journal = {Science Bulletin},
  year = {2026},
  volume = {71},
  number = {11},
  pages = {2740--2757},
  doi = {10.1016/j.scib.2026.03.050}
}
Kostenlos starten →